Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress.
第一作者:
Iryna A,Khasabova
第一单位:
Department of Diagnostic and Biological Sciences, School of Dentistry, University of Minnesota, Minneapolis, MN, United States.
作者:
医学主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞, 培养的(Cells, Cultured);顺铂(Cisplatin);疾病模型, 动物(Disease Models, Animal);女(雌)性(Female);神经节, 脊(Ganglia, Spinal);痛觉过敏(Hyperalgesia);降血糖药(Hypoglycemic Agents);男(雄)性(Male);小鼠(Mice);线粒体(Mitochondria);神经痛(Neuralgia);神经元(Neurons);氧化性应激(Oxidative Stress);PPARγ(PPAR gamma);痛阈(Pain Threshold);超氧化物歧化酶(Superoxide Dismutase)
DOI
10.1097/j.pain.0000000000001448
PMID
30507781
发布时间
2021-01-14
- 浏览8
Pain
688-701页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



